Skye Bioscience, Inc. (SKYE)
Nasdaq: SKYE · Pharmaceutical Preparations · San Diego, CA · filing with the SEC since 2011
Who runs Skye Bioscience, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Dhillon Punit
Chief Executive Officer. First filing Jan 2018, latest Aug 7, 2026, 4 filings in all.
Officers reporting now
6
of 11 people with a filing in the last fifteen months
Directors reporting now
5
24 people on the record since 2014
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Dhillon Punit | Chief Executive Officer | Jan 2018 | Aug 7, 2026 | none |
| Sharp John P | Chief Financial Officer | Apr 2026 | Apr 28, 2026 | none |
| Diep Tuan Tu | Chief Operating Officer | Feb 2024 | Apr 2, 2026 | none |
| Twitty Christopher | Chief Scientific Officer | Apr 2025 | Apr 2, 2026 | none |
| Arsenault Kaitlyn Melanie | Chief Financial Officer | Oct 2021 | Feb 9, 2026 | none |
| Arora Puneet S. | Chief Medical Officer | Sep 2024 | Feb 9, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Schwab Andrew J. | director | Aug 2023 | Sep 24, 2026 | 15 · $400,000 |
| Charych Deborah H. | director | Feb 2023 | Apr 2, 2026 | none |
| Grayson Paul A. | director | Aug 2023 | Apr 2, 2026 | none |
| Jenkins Annalisa | director | Mar 2024 | Apr 2, 2026 | none |
| Smith Karen L. | director | Jul 2024 | Apr 2, 2026 | none |
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| 5am Co-Investors II LP | 10% owner | Aug 2023 | Sep 24, 2026 | none |
| 5am Partners II, LLC | 10% owner | Aug 2023 | Sep 24, 2026 | 9 · $100,000 |
| 5am Partners Vii, LLC | 10% owner | Aug 2023 | Sep 24, 2026 | none |
| 5am Ventures II LP | 10% owner | Aug 2023 | Sep 24, 2026 | 4 · $200,000 |
| 5am Ventures Vii, L.P. | 10% owner | Aug 2023 | Sep 24, 2026 | none |
| Diekman John D | 10% owner | Aug 2023 | Sep 24, 2026 | none |
| Parmar Kush | 10% owner | Aug 2023 | Sep 24, 2026 | 2 · $100,000 |
| Rocklage Scott M | 10% owner | Aug 2023 | Sep 24, 2026 | none |
Earlier names on the record18, newest filing first
Dalesandro Margaret · director · last filing Mar 2024Tyle Praveen · director · last filing Mar 2024Ward Keith Wayne · director · last filing Mar 2024Versant Side Fund III, L.P. · 10% owner · last filing Aug 2023Versant Venture Capital III, L.P. · 10% owner · last filing Aug 2023Versant Ventures III, LLC · 10% owner · last filing Aug 2023Emerald Health Sciences Inc. · 10% owner · last filing Mar 2023Rai Sukhwinder Singh · director · last filing Jan 2023Heppell James L · director · last filing Sep 2021Janney Richard · officer · last filing Oct 2020Traistaru Elena · officer · last filing Aug 2020Kim Dennis D · officer · last filing Aug 2020Dhillon Avtar S · director · last filing Oct 2018Cesario Douglas A · officer · last filing Jul 2018Murphy Brian Stuart · officer · last filing Jan 2018Lykos Cosmas N · officer · last filing Jan 2018Berecz Elizabeth · officer · last filing Jan 2018Lapham Reg Alexander · 10% owner · last filing Mar 2017
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.